$KRMD
KORU Medical Systems, Inc. Stock $krmd

$krmd Overview Financials Valuation SEC Filings Company Website

2011 Q1 Form 10-K Financial Statement

#000116169712000406 Filed on May 29, 2012

Income Statement

Concept	2011 Q1	2011	2010 Q1
Revenue	$1.600M	$4.921M	$1.120M
YoY Change	42.86%	0.01%	17.89%
Cost Of Revenue	$520.0K	$1.657M	$330.0K
YoY Change	57.58%	-0.17%	3.13%
Gross Profit	$1.090M	$3.264M	$780.0K
YoY Change	39.74%	0.11%	23.81%
Gross Profit Margin	68.13%	66.32%	69.64%
Selling, General & Admin	$470.0K	$1.967M	$440.0K
YoY Change	6.82%	-0.13%	10.0%
% of Gross Profit	43.12%	60.28%	56.41%
Research & Development	$10.00K	$35.52K	$10.00K
YoY Change	0.0%	-11.2%	0.0%
% of Gross Profit	0.92%	1.09%	1.28%
Depreciation & Amortization	$20.00K	$65.77K	$10.00K
YoY Change	100.0%	-6.04%	-50.0%
% of Gross Profit	1.83%	2.02%	1.28%
Operating Expenses	$490.0K	$2.003M	$460.0K
YoY Change	6.52%	-3.24%	9.52%
Operating Profit	$600.0K	$1.195M	$320.0K
YoY Change	87.5%	0.41%	52.38%
Interest Expense	$0.00	$36.39K	-$20.00K
YoY Change	-100.0%	-221.31%	0.0%
% of Operating Profit	0.0%	3.05%	-6.25%
Other Income/Expense, Net		-$1.710K
YoY Change
Pretax Income	$590.0K	$1.193M	$300.0K
YoY Change	96.67%	0.26%	57.89%
Income Tax	$240.0K	$489.0K	-$360.0K
% Of Pretax Income	40.68%	40.99%	-120.0%
Net Earnings	$350.0K	$704.1K	$660.0K
YoY Change	-46.97%	0.58%	32.0%
Net Earnings / Revenue	21.88%	14.31%	58.93%
Basic Earnings Per Share		$0.02
Diluted Earnings Per Share	$9.406K	$0.02	$18.55K
COMMON SHARES
Basic Shares Outstanding		36.24M
Diluted Shares Outstanding		36.85M

Balance Sheet

Concept	2011 Q1	2011	2010 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$1.470M	$2.010M	$810.0K
YoY Change	81.48%	36.73%	55.77%
Cash & Equivalents	$1.322M	$1.760M	$813.4K
Short-Term Investments	$150.0K	$260.0K	$0.00
Other Short-Term Assets	$160.0K	$190.0K	$380.0K
YoY Change	-57.89%	18.75%	0.0%
Inventory	$668.2K	$1.170M	$630.0K
Prepaid Expenses	$112.9K
Receivables	$713.9K	$880.0K	$650.0K
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$3.015M	$4.250M	$2.480M
YoY Change	21.59%	40.73%	23.38%
LONG-TERM ASSETS
Property, Plant & Equipment	$361.4K	$500.0K	$220.0K
YoY Change	64.25%	38.89%	-4.35%
Goodwill
YoY Change
Intangibles	$29.84K
YoY Change
Long-Term Investments
YoY Change
Other Assets	$58.00K	$30.00K	$250.0K
YoY Change	-76.8%	0.0%	733.33%
Total Long-Term Assets	$419.4K	$560.0K	$510.0K
YoY Change	-17.77%	36.59%	70.0%
TOTAL ASSETS
Total Short-Term Assets	$3.015M	$4.250M	$2.480M
Total Long-Term Assets	$419.4K	$560.0K	$510.0K
Total Assets	$3.435M	$4.810M	$2.990M
YoY Change	14.87%	40.23%	29.44%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$158.1K	$200.0K	$80.00K
YoY Change	97.64%	25.0%	-63.64%
Accrued Expenses	$71.33K	$290.0K	$250.0K
YoY Change	-71.47%	222.22%	-3.85%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$40.00K	$40.00K	$70.00K
YoY Change	-42.86%	0.0%	-41.67%
Total Short-Term Liabilities	$314.1K	$560.0K	$500.0K
YoY Change	-37.19%	80.65%	-30.56%
LONG-TERM LIABILITIES
Long-Term Debt	$480.0K	$440.0K	$620.0K
YoY Change	-22.58%	-8.33%	-8.82%
Other Long-Term Liabilities	$160.0K	$130.0K	$180.0K
YoY Change	-11.11%	-18.75%	-10.0%
Total Long-Term Liabilities	$640.2K	$570.0K	$800.0K
YoY Change	-19.98%	-10.94%	-9.09%
TOTAL LIABILITIES
Total Short-Term Liabilities	$314.1K	$560.0K	$500.0K
Total Long-Term Liabilities	$640.2K	$570.0K	$800.0K
Total Liabilities	$954.2K	$1.250M	$1.300M
YoY Change	-26.6%	31.58%	-19.25%
SHAREHOLDERS EQUITY
Retained Earnings	-$761.1K
YoY Change
Common Stock	$3.384M
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)	$142.0K
YoY Change
Treasury Stock Shares	$2.275M
Shareholders Equity	$2.480M	$3.550M	$1.689M
YoY Change
Total Liabilities & Shareholders Equity	$3.435M	$4.810M	$2.990M
YoY Change	14.87%	40.23%	29.44%

Cashflow Statement

Concept	2011 Q1	2011	2010 Q1
OPERATING ACTIVITIES
Net Income	$350.0K	$704.1K	$660.0K
YoY Change	-46.97%	0.58%	32.0%
Depreciation, Depletion And Amortization	$20.00K	$65.77K	$10.00K
YoY Change	100.0%	-6.04%	-50.0%
Cash From Operating Activities	$240.0K	$1.028M	$250.0K
YoY Change	-4.0%	-0.15%	13.64%
INVESTING ACTIVITIES
Capital Expenditures	-$110.0K	$200.5K	-$10.00K
YoY Change	1000.0%	-200.26%	-75.0%
Acquisitions
YoY Change
Other Investing Activities	-$150.0K	-$100.0K	$0.00
YoY Change		-33.33%
Cash From Investing Activities	-$260.0K	-$353.4K	-$10.00K
YoY Change	2500.0%	0.96%	-75.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net		$0.00
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-10.00K	-$166.2K	-10.00K
YoY Change	0.0%	-2.22%
NET CHANGE
Cash From Operating Activities	240.0K	$1.028M	250.0K
Cash From Investing Activities	-260.0K	-$353.4K	-10.00K
Cash From Financing Activities	-10.00K	-$166.2K	-10.00K
Net Change In Cash	-30.00K	$508.9K	230.0K
YoY Change	-113.04%	-0.22%	27.78%
FREE CASH FLOW
Cash From Operating Activities	$240.0K	$1.028M	$250.0K
Capital Expenditures	-$110.0K	$200.5K	-$10.00K
Free Cash Flow	$350.0K	$827.9K	$260.0K
YoY Change	34.62%	-32.69%	0.0%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2012	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--02-29
CY2012	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2012	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2012
CY2012	dei	Document Period End Date DocumentPeriodEndDate	2012-02-29
CY2012	dei	Amendment Flag AmendmentFlag	false
CY2012	dei	Document Type DocumentType	10-K
CY2012	dei	Entity Central Index Key EntityCentralIndexKey	0000704440
CY2012Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	35196667
CY2012	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2012	dei	Entity Filer Category EntityFilerCategory	Smaller Reporting Company
CY2011Q3	dei	Entity Public Float EntityPublicFloat	9183793	USD
CY2012	dei	Entity Registrant Name EntityRegistrantName	REPRO MED SYSTEMS INC
CY2012	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2012	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2011	repr	Conversion Of Preferred Stock Into Common Stock By Director Price Per Share ConversionOfPreferredStockIntoCommonStockByDirectorPricePerShare	0.105
CY2011	repr	Issuance Of Common Stock As Employee Incentive Price Per Share IssuanceOfCommonStockAsEmployeeIncentivePricePerShare	0.17
CY2011	repr	Issuance Of Common Stock As Incentive For Property Owner Maintenance Price Per Share IssuanceOfCommonStockAsIncentiveForPropertyOwnerMaintenancePricePerShare	0.17
CY2012	repr	Issuance Of Common Stock For Exercised Stock Options Price Per Share IssuanceOfCommonStockForExercisedStockOptionsPricePerShare	0.06
CY2011	repr	Reversal Of Accrued Preferred Stock Dividends ReversalOfAccruedPreferredStockDividends	68000	USD
CY2012Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	199527	USD
CY2011Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	158108	USD
CY2012Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	884727	USD
CY2011Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	713906	USD
CY2012Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	153800	USD
CY2011Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	71330	USD
CY2012Q1	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	3263244	USD
CY2011Q1	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	3017809	USD
CY2011	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	12511	USD
CY2012	us-gaap	Adjustments To Additional Paid In Capital Tax Effect From Share Based Compensation AdjustmentsToAdditionalPaidInCapitalTaxEffectFromShareBasedCompensation	132875	USD
CY2012Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	17718	USD
CY2011Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	12128	USD
CY2012Q1	us-gaap	Assets Assets	4805145	USD
CY2011Q1	us-gaap	Assets Assets	3434688	USD
CY2012Q1	us-gaap	Assets Current AssetsCurrent	4253536	USD
CY2011Q1	us-gaap	Assets Current AssetsCurrent	3015333	USD
CY2012Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1757223	USD
CY2011Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1322250	USD
CY2010Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	813383	USD
CY2012	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	434973	USD
CY2011	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	508867	USD
CY2012Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2011Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2012Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	50000000
CY2011Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	50000000
CY2012Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	37471667
CY2011Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	36577667
CY2012Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	35196667
CY2011Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	34302667
CY2012Q1	us-gaap	Common Stock Value CommonStockValue	374717	USD
CY2011Q1	us-gaap	Common Stock Value CommonStockValue	365777	USD
CY2012	us-gaap	Conversion Of Stock Amount Issued1 ConversionOfStockAmountIssued1		USD
CY2011	us-gaap	Conversion Of Stock Amount Issued1 ConversionOfStockAmountIssued1	100000	USD
CY2012	us-gaap	Cost Of Goods Sold CostOfGoodsSold	2251398	USD
CY2011	us-gaap	Cost Of Goods Sold CostOfGoodsSold	1657184	USD
CY2012	us-gaap	Costs And Expenses CostsAndExpenses	5101376	USD
CY2011	us-gaap	Costs And Expenses CostsAndExpenses	3725894	USD
CY2012	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	167004	USD
CY2011	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	487343	USD
CY2012Q1	us-gaap	Deferred Tax Assets Net Current DeferredTaxAssetsNetCurrent		USD
CY2011Q1	us-gaap	Deferred Tax Assets Net Current DeferredTaxAssetsNetCurrent	45641	USD
CY2012Q1	us-gaap	Deferred Tax Liabilities Noncurrent DeferredTaxLiabilitiesNoncurrent	121363	USD
CY2011Q1	us-gaap	Deferred Tax Liabilities Noncurrent DeferredTaxLiabilitiesNoncurrent		USD
CY2012Q1	us-gaap	Deposits Assets Current DepositsAssetsCurrent	255228	USD
CY2011Q1	us-gaap	Deposits Assets Current DepositsAssetsCurrent	152399	USD
CY2012Q1	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	28156	USD
CY2011Q1	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	28156	USD
CY2012	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	103981	USD
CY2011	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	65774	USD
CY2012	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.02
CY2011	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.02
CY2012	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.02
CY2011	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.02
CY2012Q1	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	41551	USD
CY2011Q1	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	21195	USD
CY2012	us-gaap	Excess Tax Benefit From Share Based Compensation Financing Activities ExcessTaxBenefitFromShareBasedCompensationFinancingActivities	132875	USD
CY2011	us-gaap	Excess Tax Benefit From Share Based Compensation Financing Activities ExcessTaxBenefitFromShareBasedCompensationFinancingActivities		USD
CY2012Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	107640	USD
CY2011Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	102314	USD
CY2012	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	10718	USD
CY2011	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-2461	USD
CY2012	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	1281184	USD
CY2011	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	1193119	USD
CY2012	us-gaap	Income Taxes Paid IncomeTaxesPaid	89644	USD
CY2011	us-gaap	Income Taxes Paid IncomeTaxesPaid		USD
CY2012	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	465291	USD
CY2011	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	489034	USD
CY2012	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	41419	USD
CY2011	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	77391	USD
CY2012	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	170821	USD
CY2011	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	58946	USD
CY2012	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	82470	USD
CY2011	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-47410	USD
CY2012	us-gaap	Increase Decrease In Accrued Taxes Payable IncreaseDecreaseInAccruedTaxesPayable	98000	USD
CY2011	us-gaap	Increase Decrease In Accrued Taxes Payable IncreaseDecreaseInAccruedTaxesPayable		USD
CY2012	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	20356	USD
CY2011	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	8540	USD
CY2012	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet		USD
CY2011	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	-54183	USD
CY2012	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	499256	USD
CY2011	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	33616	USD
CY2012	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities		USD
CY2011	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	-72188	USD
CY2012	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	75965	USD
CY2011	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	45326	USD
CY2012Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	24513	USD
CY2011Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	29839	USD
CY2012	us-gaap	Interest Expense InterestExpense	31540	USD
CY2011	us-gaap	Interest Expense InterestExpense	36392	USD
CY2012	us-gaap	Interest Paid InterestPaid	31540	USD
CY2011	us-gaap	Interest Paid InterestPaid	36392	USD
CY2012Q1	us-gaap	Inventory Net InventoryNet	1167456	USD
CY2011Q1	us-gaap	Inventory Net InventoryNet	668200	USD
CY2012	us-gaap	Investment Income Net InvestmentIncomeNet	12848	USD
CY2011	us-gaap	Investment Income Net InvestmentIncomeNet	8718	USD
CY2012	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims		USD
CY2011	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	6970	USD
CY2012Q1	us-gaap	Liabilities Liabilities	1254417	USD
CY2011Q1	us-gaap	Liabilities Liabilities	954228	USD
CY2012Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	4805145	USD
CY2011Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	3434688	USD
CY2012Q1	us-gaap	Liabilities Current LiabilitiesCurrent	558853	USD
CY2011Q1	us-gaap	Liabilities Current LiabilitiesCurrent	314053	USD
CY2012Q1	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	695564	USD
CY2011Q1	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	640175	USD
CY2012Q1	us-gaap	Long Term Notes Payable LongTermNotesPayable	1474	USD
CY2011Q1	us-gaap	Long Term Notes Payable LongTermNotesPayable	3552	USD
CY2012	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	213436	USD
CY2011	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-166227	USD
CY2012	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-339064	USD
CY2011	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-353371	USD
CY2012	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	560601	USD
CY2011	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	1028465	USD
CY2012	us-gaap	Net Income Loss NetIncomeLoss	815893	USD
CY2011	us-gaap	Net Income Loss NetIncomeLoss	704085	USD
CY2012	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-7974	USD
CY2011	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-1710	USD
CY2012Q1	us-gaap	Notes Payable Current NotesPayableCurrent	2077	USD
CY2011Q1	us-gaap	Notes Payable Current NotesPayableCurrent	1928	USD
CY2012Q1	us-gaap	Notes Payable Related Parties Classified Current NotesPayableRelatedPartiesClassifiedCurrent	41417	USD
CY2011Q1	us-gaap	Notes Payable Related Parties Classified Current NotesPayableRelatedPartiesClassifiedCurrent	39011	USD
CY2012Q1	us-gaap	Notes Payable Related Parties Noncurrent NotesPayableRelatedPartiesNoncurrent	437832	USD
CY2011Q1	us-gaap	Notes Payable Related Parties Noncurrent NotesPayableRelatedPartiesNoncurrent	479248	USD
CY2012	us-gaap	Operating Income Loss OperatingIncomeLoss	1289158	USD
CY2011	us-gaap	Operating Income Loss OperatingIncomeLoss	1194829	USD
CY2012Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	52669	USD
CY2011Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	57995	USD
CY2012Q1	us-gaap	Other Deferred Credits Current OtherDeferredCreditsCurrent	22481	USD
CY2011Q1	us-gaap	Other Deferred Credits Current OtherDeferredCreditsCurrent	22481	USD
CY2012Q1	us-gaap	Other Deferred Credits Noncurrent OtherDeferredCreditsNoncurrent	134895	USD
CY2011Q1	us-gaap	Other Deferred Credits Noncurrent OtherDeferredCreditsNoncurrent	157375	USD
CY2012	us-gaap	Other Noncash Income OtherNoncashIncome	22480	USD
CY2011	us-gaap	Other Noncash Income OtherNoncashIncome	22480	USD
CY2012	us-gaap	Other Nonoperating Income OtherNonoperatingIncome		USD
CY2011	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	28425	USD
CY2012	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	236235	USD
CY2011	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	200522	USD
CY2012	us-gaap	Payments To Acquire Restricted Certificates Of Deposit PaymentsToAcquireRestrictedCertificatesOfDeposit	102829	USD
CY2011	us-gaap	Payments To Acquire Restricted Certificates Of Deposit PaymentsToAcquireRestrictedCertificatesOfDeposit	152399	USD
CY2012Q1	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	188902	USD
CY2011Q1	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	112937	USD
CY2012	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	121500	USD
CY2011	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock		USD
CY2012	us-gaap	Proceeds From Sale Of Intangible Assets ProceedsFromSaleOfIntangibleAssets		USD
CY2011	us-gaap	Proceeds From Sale Of Intangible Assets ProceedsFromSaleOfIntangibleAssets	-450	USD
CY2012Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	498940	USD
CY2011Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	361360	USD
CY2012	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	1929	USD
CY2011	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	29483	USD
CY2012	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	39010	USD
CY2011	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	136744	USD
CY2012	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	90329	USD
CY2011	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	35519	USD
CY2012Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	54767	USD
CY2011Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-761126	USD
CY2012	us-gaap	Sales Revenue Net SalesRevenueNet	6390534	USD
CY2011	us-gaap	Sales Revenue Net SalesRevenueNet	4920723	USD
CY2012	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	2655668	USD
CY2011	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	1967417	USD
CY2012	us-gaap	Share Based Compensation ShareBasedCompensation		USD
CY2011	us-gaap	Share Based Compensation ShareBasedCompensation	12511	USD
CY2012Q1	us-gaap	Stockholders Equity StockholdersEquity	3550728	USD
CY2011Q1	us-gaap	Stockholders Equity StockholdersEquity	2480460	USD
CY2010Q1	us-gaap	Stockholders Equity StockholdersEquity	1688894	USD
CY2012Q1	us-gaap	Stockholders Equity Before Treasury Stock StockholdersEquityBeforeTreasuryStock	3692728	USD
CY2011Q1	us-gaap	Stockholders Equity Before Treasury Stock StockholdersEquityBeforeTreasuryStock	2622460	USD
CY2012	us-gaap	Stockholders Equity Other StockholdersEquityOther		USD
CY2012	us-gaap	Stock Issued1 StockIssued1		USD
CY2011	us-gaap	Stock Issued1 StockIssued1	6970	USD
CY2011	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities Net Of Adjustments StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments		USD
CY2011	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	5950	USD
CY2011	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	1020	USD
CY2012	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	121500	USD
CY2012Q1	us-gaap	Taxes Payable Current TaxesPayableCurrent	98000	USD
CY2011Q1	us-gaap	Taxes Payable Current TaxesPayableCurrent		USD
CY2012Q1	us-gaap	Treasury Stock Shares TreasuryStockShares	2275000
CY2011Q1	us-gaap	Treasury Stock Shares TreasuryStockShares	2275000
CY2012Q1	us-gaap	Treasury Stock Value TreasuryStockValue	142000	USD
CY2011Q1	us-gaap	Treasury Stock Value TreasuryStockValue	142000	USD
CY2012	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	35102446
CY2011	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	36850760
CY2012	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	34250560
CY2011	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	36244542

Files In Submission

Name	View Source	Status
0001161697-12-000406-index-headers.html	Edgar Link	pending
0001161697-12-000406-index.html	Edgar Link	pending
0001161697-12-000406.txt	Edgar Link	pending
0001161697-12-000406-xbrl.zip	Edgar Link	pending
ex_14-1.htm	Edgar Link	pending
ex_14-2.htm	Edgar Link	pending
ex_14-3.htm	Edgar Link	pending
ex_31-1.htm	Edgar Link	pending
ex_31-2.htm	Edgar Link	pending
ex_32-1.htm	Edgar Link	pending
ex_32-2.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xls	Edgar Link	pending
form_10-k.htm	Edgar Link	pending
mcgladrey_logo.jpg	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
repr-20120229.xml	Edgar Link	completed
repr-20120229.xsd	Edgar Link	pending
repr-20120229_cal.xml	Edgar Link	unprocessable
repr-20120229_def.xml	Edgar Link	unprocessable
repr-20120229_lab.xml	Edgar Link	unprocessable
repr-20120229_pre.xml	Edgar Link	unprocessable
rms_logo.jpg	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$KRMD
KORU Medical Systems, Inc. Stock $krmd

2011 Q1 Form 10-K Financial Statement

#000116169712000406 Filed on May 29, 2012

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$KRMD KORU Medical Systems, Inc. Stock $krmd

2011 Q1 Form 10-K Financial Statement

#000116169712000406 Filed on May 29, 2012

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$KRMD
KORU Medical Systems, Inc. Stock $krmd